Enteric bacteria possess a multifunctional flavoprotein, called proline utilization A (PutA), that acts as both a membraneassociated proline catabolic enzyme and a transcriptional repressor of proline utilization (put) genes. Peripherally membrane-bound PutA catalyzes the two-step oxidation of proline to glutamate [1] [2] [3] (Fig. 1) , whereas cytoplasmic PutA regulates proline catabolism by repressing the transcription of its own gene and the gene for the PutP Na + /proline transporter [4] [5] [6] . Together, PutA and PutP enable enteric bacteria to use proline as a source of carbon, nitrogen and electrons 5, 6 .
Proline availability is the environmental cue that dictates the intracellular location and function of PutA [7] [8] [9] [10] . In the absence of proline, PutA accumulates in the cytoplasm and represses the divergent transcription of the put regulon by binding to several sites in the 419-base pair (bp) intergenic region between putP and putA. In the presence of proline, PutA associates with the membrane, where it performs its enzymatic functions. Proline is oxidized to ∆ 1 -pyrroline-5-carboxylate (P5C) in the first, proline dehydrogenase (PRODH) step of catalysis, which is coupled to the two-electron reduction of the noncovalently bound FAD (Fig. 1) . Electrons from the reduced FAD are subsequently transferred to an acceptor in the electron transport chain. Because proline reduces FAD in the PRODH step of catalysis, the FAD redox state is implicated as a regulatory mechanism for the association of PutA with the membrane. In the second step of catalysis, glutamic semialdehyde, presumably the product of nonenzymatic hydrolysis of P5C, is oxidized to glutamate by the P5C dehydrogenase (P5CDH) domain of PutA, thus reducing NAD + to NADH (Fig. 1) .
Although the functions of PutA are well documented, this protein remains enigmatic because of a complete lack of threedimensional structure information for PutA and its domains.
Thus, we have initiated X-ray crystallographic studies of the E. coli protein to establish a structural framework for investigating catalytic and repressor functions of PutA and to identify conformational changes caused by substrate binding and flavin reduction.
In a larger context, the two enzymatic reactions catalyzed by the PutA protein ( Fig. 1) The PutA flavoprotein from Escherichia coli plays multiple roles in proline catabolism by functioning as a membrane-associated bi-functional enzyme and a transcriptional repressor of proline utilization genes. The human homolog of the PutA proline dehydrogenase (PRODH) domain is critical in p53-mediated apoptosis and schizophrenia. Here we report the crystal structure of a 669-residue truncated form of PutA that shows both PRODH and DNA-binding activities, representing the first structure of a PutA protein and a PRODH enzyme from any organism. The structure is a domain-swapped dimer with each subunit comprising three domains: a helical dimerization arm, a 120-residue domain containing a three-helix bundle similar to that in the helix-turn-helix superfamily of DNA-binding proteins and a ␤/␣-barrel PRODH domain with a bound lactate inhibitor. Analysis of the structure provides insight into the mechanism of proline oxidation to pyrroline-5-carboxylate, and functional studies of a mutant protein suggest that the DNA-binding domain is located within the N-terminal 261 residues of E. coli PutA. separate genes. The human homolog of the PutA PRODH domain -known variously as hsPRODH2, PIG6 (for p53-induced gene 6) 11 and proline oxidase 12 -is a mitochondrial enzyme of significant interest because of its roles in p53-mediated apoptosis 11 , proline-dependent reactive oxygen species generation 12 and schizophrenia 13 . The involvement of hsPRODH2 in the devastating mental illness schizophrenia is particularly compelling. Recent molecular genetics studies based on patients with adult or childhood onset schizophrenia strongly suggest that genetic variations in the hsPRODH2 gene increase the risk of susceptibility to schizophrenia 13 . Several of these variations result in missense changes at conserved amino acid residues; thus, the encoded enzyme may not be fully functional. The precise role of hsPRODH2 in schizophrenia is yet to be determined, but one intriguing possibility is that proline may serve as a direct modulator of glutamatergic transmission in the brain and that elevated proline levels caused by impaired hsPRODH2 activity contribute to the onset of schizophrenia 13, 14 .
To provide a structural foundation for understanding the multifunctional E. coli PutA protein, as well as PRODH enzymes from other organisms, we determined the crystal structure of a protein (PutA669) corresponding to the N-terminal 669 residues of the 1,320-amino acid E. coli PutA polypeptide chain. PutA669 binds FAD, shows the PRODH activity of the fulllength PutA protein and binds specifically to the put intergenic DNA with a dissociation constant of 15 nM (ref. 15 ). Thus, PutA669 is a good model system for understanding the PRODH and DNAbinding functions of PutA. In contrast, PutA669 does not contain the P5C dehydrogenase domain, which is located within residues 650-1,130 (based on sequence alignments) 16 , nor does it show the membrane association activity of PutA 15 . Therefore, the PutA669 structure provides little insight into other aspects of PutA function, such as the mechanism by which flavin reduction induces membrane binding, and the structural basis of PutA-membrane association.
Overall structure
The PutA669 crystal structure is the first structure of a PutA protein and a PRODH enzyme from any organism. PutA669 is a homodimer of interlocking subunits with overall dimensions of 97 Å × 57 Å × 50 Å (Fig. 2a ). The dimeric model was generated from the subunit in the asymmetric unit by a crystallographic two-fold rotation around the c-axis. This particular mode of dimerization was identified by virtue of its large interfacial buried surface area (9,002 Å 2 ). Note that PutA669, similar to PutA, forms a dimer in solution according to gel filtration studies 15 .
Each subunit comprises three structurally distinct domains. Domain I (residues 87-139) consists of three α-helices (αA, αB and αC) that form an arm that reaches out from one subunit to embrace the other subunit, thus creating an interlocking, or three-dimensional, domain-swapped 17 dimer (Fig. 2a) . Domain II (140-260) is a cluster of six α-helices labeled αD-αI (Fig. 2b) . This domain does not make significant intersubunit contacts and does not contribute resides to the active site. Thus, the function of domain II is not immediately apparent from its structure. Domain III (residues 261-612) is a β 8 α 8 -barrel that binds FAD at the C-terminal ends of the β-strands of the barrel (Fig. 2c) ; thus, domain III performs the PRODH function of PutA669.
The proline dehydrogenase domain
The PutA669 structure is only the second example of a FAD cofactor bound to a β 8 α 8 -barrel, with the other example being methylenetetrahydrofolate reductase (MTHFR) 18 . The FAD binds with its pyrimidine carbonyls directed toward strand β3 and the dimethyl benzene edge of the FAD isoalloxazine near strand β7 (Fig. 2c) , which is similar to the orientation of FAD in the barrel of MTHFR. Strands 4-6 support the re face of the isoalloxazine, and the ribityl and pyrophosphate groups insert between strands β5 and β6. The adenine sits above the rim of the barrel, where it is wedged between helices α5a and α5.
The discovery of the competitive inhibitor L-lactate bound to the enzyme provides insight into the identity of active site residues. Lactate binds near the pyrimidine portion of the si face of the FAD isoalloxazine (Fig. 3a) , with its carboxylate bound by three basic residues: Lys329, Arg555 and Arg556 (Fig. 3b) . The ion pair network involving Glu559, Glu289, Asp370 and Arg431 stabilizes these three residues. Residues Arg556 and Glu559 hydrogen bond to the flavin ribityl, and Arg431 donates a hydrogen bond to the N5 of FAD. The lactate hydroxyl forms hydrogen bonds to Asp370, Tyr540 and a water molecule (Wat1). Wat1, in turn, hydrogen bonds to Tyr437. Finally, the lactate methyl group forms van der Waals interactions with Leu513.
All the aforementioned active site residues are highly conserved in sequences of bacterial PutA proteins and eukaryotic PRODH enzymes from various organisms, with overall sequence identities to E. coli PutA of 19-90%. Thus, the PutA669 structure serves as the prototype for FAD-dependent proline dehydrogenase domains. In particular, the active site residues of PutA669 display a high degree of sequence conservation with hsPRODH2. Of the 40 residues within 5 Å of FAD or lactate, 19 are identical in the hsPRODH2 sequence and 6 residues display conservative substitutions. Such extensive conservation (47% identity and 62% similarity) makes a case for PutA669 and hsPRODH2 sharing a common active site and possibly a common fold, and for the PutA669 PRODH domain structure providing a threedimensional framework for understanding the function of hsPRODH2 and its role in disease.
The bound inhibitor was used to model the binding of the substrate proline to PutA669 so that residues could be identified that contact the substrate and hypotheses about the catalytic mechanism could be generated. Our model shows that the proline C5-H bond points toward the flavin N5 with a C5-N5 distance of 3.2 Å (Fig. 3c) , which is consistent with a direct hydride transfer mechanism. For example, similar ligand-FAD geometries are observed in structures of D-amino acid oxidase (DAAO), which catalyzes the oxidation of D-amino acids to imino acids 19, 20 , a reaction analogous to that of PutA669. The direct hydride transfer mechanism has been implicated in DAAO on the basis of structural 19, 20 and kinetic 21, 22 data.
Asp370, Tyr540 and Leu513 interact with the methylene groups of proline (Fig. 3d ). Asp370 and Tyr540 seem to form the ceiling of the active site, and they are held in place by a hydrogen bond between them, while Leu513 forms the right-hand wall of the active site. These three side chains may play a role in catalysis by enforcing size and shape requirements on the substrate. Wat1 is located 2.9 Å from the proline N atom and, thus, could stabilize the substrate and P5C product through hydrogen bonding (Fig. 3d) . Presumably, a base in the active site serves to accept a proton from the substrate N atom, assuming the zwitterionic form of proline binds in the active site (pK a = 10.5). There are several possible groups that could potentially play this role, including Asp370, Tyr437 and Wat1 (Fig. 3d) . Mutagenesis studies and crystal structures of PutA669 in complex with proline and proline analogs should provide insight into this aspect of the catalytic mechanism.
Conventional understanding holds that hydrolysis of P5C to glutamic semi-aldehyde occurs non-enzymatically after the P5C product exits the active site. The structure suggests that this step of catalysis might occur within the active site because of the proximity of Wat1 to proline in the model. Note that attack of Wat1 on P5C would require a counterclockwise rotation of P5C relative to the orientation of proline (Fig. 3d) to bring C5 close to Wat1. Performing the hydrolysis reaction within the active site could offer a catalytic advantage because the increase in molecular volume and conformational entropy resulting from conversion of P5C to glutamic semi-aldehyde should facilitate product release. Formation of the glutamic semi-aldehyde product in the PRODH active site raises the possibility of channeling between the PRODH and P5C dehydrogenase active sites, which has been proposed 23 . Because PutA669 lacks the P5C dehydrogenase domain, speculating which residues might be involved in channeling is difficult. However, the structure does suggest that the issue of channeling deserves more study.
The DNA-binding function of PutA699
In addition to its enzymatic function, PutA669 also shows the DNA-binding function of PutA 15 ; therefore, the DNA-binding apparatus is located somewhere in the first 669 residues of the PutA protein. To further isolate the part of the PutA polypeptide that interacts with DNA, a truncated protein corresponding to the first 261 residues of PutA (PutA261) was engineered, expressed in E. coli and assayed for DNA-binding activity using gel shift analysis. Note that PutA261 contains domains I and II, as well as the N-terminal 86 residues of PutA, which are disordered in the current structure. Gel shift analysis clearly shows that PutA261 inhibits the migration of the 419 bp put intergenic DNA through an agarose/polyacrylamide gel matrix (Fig. 4a,  lanes 2-5) . In addition, PutA261 does not retard the migration of ladder DNA (Fig. 4a, lane 6) , which shows that PutA261, similar to PutA and PutA669, binds specifically to the put intergenic DNA. These results show that the residues that perform the DNA-binding function of PutA are located within residues 1-261 and that the PRODH and DNA-binding activities are separable.
The PutA669 structure and the PutA261 functional results suggest three possible candidates for the DNA-binding domain of PutA: residues 1-86, domain I and domain II. Residues 1-86 are disordered in the current crystal structure; therefore, the structure does not provide insight into the functional role of these residues. Domain I is involved in dimerization by forming many intimate contacts with the barrel of the opposite subunit (Fig. 2a) . Direct participation of this domain in DNA association seems unlikely in dimer formation. Domain II (Fig. 2b) is not involved in catalysis or in dimerization; thus, by the process of elimination, this domain probably functions in binding DNA.
To provide support for the idea that domain II is involved in DNA association, Dali 24 was used to determine whether domain II bears any structural similarity to known DNA-binding proteins. Dali failed to find a domain in the Protein Data Bank with high global structural similarity to domain II, which suggests that domain II might represent a novel protein fold. In contrast, Dali found a significant local structural similarity between the helix-turn-helix (HTH) superfamily of DNA-binding proteins and helices αE, αG and αH of domain II. In particular, Dali identified the following HTH proteins as the top three matches with the structural database: the sporulation response regulator protein Spo0A 25 (PDB entry 1FC3; Z-score = 3.7 and r.m.s. deviation = 3.6 Å), the nitrate response regulator protein NarL 26 (1A04; Z-score = 3.7 and r.m.s. deviation = 4.9 Å) and the cell division control protein Cdc6/Cdc18 (ref. 27) (1FNN; Z-score = 3.6 and r.m.s. deviation = 3.4 Å). Alignment of these proteins onto domain II revealed that helices αE, αG and αH form a three-helix bundle similar to that found in the HTH superfamily. For example, the HTH three-helix bundle of Cdc6/Cdc18 superimposes almost perfectly with helices αE, αG and αH of PutA669 (Fig. 4b) . This comparison suggests that helix αE is structurally analogous to the first helix of the HTH three-helix bundle, whereas helices αG and αH are analogous to the HTH scaffolding and recognition helices 28 .
Although PutA contains a three-helix bundle resembling those found in HTH DNA-binding proteins, the larger question a b Fig. 4 The DNA-binding function of PutA669. a, Gel mobility shift analysis of PutA proteins and the put control DNA. PutA261 (0-400 nM), PutA669 (500 nM) and PutA (500 nM) were added to separate binding mixtures in 70 mM Tris-HCl, pH 7.5, containing put control intergenic DNA (20 nM) at 20 °C. Nonspecific ΦX174 ladder DNA (20 µg ml -1 ) was also added to binding mixtures containing 0 nM and 400 nM PutA261. The complexes were separated using an agarose/polyacrylamide (0.5%/3%) native gel at 4 °C. The gel was stained with ethidium bromide to visualize the put DNAprotein complexes and the ΦX174 ladder DNA. b, Comparison of PutA669 domain II (blue) and the HTH three-helix bundle of Cdc6/Cdc18 (yellow, PDB entry 1FNN, residues Ala287-Alal343). The orientation is identical to that of (Fig. 2b) . The dashed curves represent disordered residues in PutA669.
of how PutA uses its HTH substructure, if at all, to perform its repressor function remains unanswered. The structure presented here provides a foundation for designing biochemical experiments, such as mutagenesis, that will help answer this question. Ultimately, the crystal structures of PutA proteins in complex with DNA will be needed to fully understand how E. coli PutA functions as both an enzyme and a transcriptional repressor.
Methods
Crystallization and heavy atom derivative preparation. PutA669 was expressed in E. coli, purified and crystallized as described 29 . Crystals were grown in hanging drops over a reservoir of 21-26% (w/v) PEG 3000 and 0.1 M sodium citrate buffer, pH 6-7. The crystals occupy space group I222, with unit cell dimensions a = 72.62 Å, b = 140.43 Å and c = 145.85 Å, and the asymmetric unit contains one PutA669 monomer 29 . Halide derivatives for phase determination were prepared by soaking native crystals for 30 s in the cryobuffer (24% (w/v) PEG 3000, 10% (v/v) PEG 200 and 0.1 M sodium citrate buffer, pH 6.6) supplemented with either 0.5 M NaBr or 0.25 M KI. A mercury derivative was obtained from a 4 h soak in cryobuffer containing 4 mM thimerosal.
Data collection and structure determination. The structure was solved to 2.0 Å resolution by multiple isomorphous replacement with anomalous scattering (MIRAS; Table 1 ). Data from native and KI-derivative crystals were collected at NSLS beamline X8-C using a wavelength of 1.0070 Å. The NaBr data were collected at APS beamline SBC19-ID using a wavelength of 0.91965 Å, which corresponded to the experimentally determined maximum of f′′. Data from the thimerosal derivative were obtained using a copper rotating anode source and an R-axis IV detector. All data collections were performed using cryocooled crystals, and the data were processed with HKL 30 . MIRAS phasing calculations were performed using CCP4 (ref. 31) . Initial phases were determined from two Hg sites located from isomorphous difference Patterson maps, and the remaining Hg sites and the halide sites were located by cross-Fourier maps calculated from these initial phases. The heavy atom parameters were refined using MLPHARE 31 , and the phases were improved by density modification using DM 31 . An initial model was built into density-modified maps using O 32 , and refinement was performed with X-PLOR 33 using all data from 30.0 to 2.0 Å. The electron density for the main chain was continuous throughout the protein, except for residues [194] [195] [196] [197] [198] [199] , 218-223 and 613-669, which apparently are disordered and, therefore, omitted from the model.
Electron density maps calculated at every stage of chain tracing and refinement clearly indicated the presence of a ligand bound near the pyrimidine portion of the si face of the FAD isoalloxazine. The shape of this feature matched that of lactate, and L-lactate is known to be a competitive inhibitor of PRODH, with a K i of 1.4 mM (ref.
3). The PEG 3000 solution used in crystallization and cryoprotection seems to be the source of L-lactate. Using a L-lactate detection assay based on NAD-linked lactate dehydrogenase and alanine aminotransferase 34 , a 50% (w/v) PEG 3000 (Fluka) solution was found to contain 3-4 mM L-lactate (M. Zhang and J.J.T., unpub. results). Thus, we concluded that the electron density feature represents a bound L-lactate molecule, and L-lactate was modeled into the density and refined (Fig. 3a) .
The refined model includes 514 of the expected 669 amino acid residues, 1 FAD, 1 L-lactate molecule and 476 water molecules. Stereochemical analysis of the final structure revealed that 87% of the nonglycine residues lie in the most favorable regions of the Ramachandran plot, with no residues in the disallowed regions 35 . The stereochemistry meets or surpasses all the main chain and side chain tests of PROCHECK 35 .
Modeling. A simple model of L-proline was constructed to identify which residues could potentially contact the substrate. A model of L-proline was superimposed onto the L-lactate molecule bound in the active site using a least squares fit based on the coordinates of the carboxylate and C2 and C3 carbon atoms. The system was then minimized without restraints using the bonded and van der Waals energy terms of CNS 36 . The only change in the active site necessi tated by the introduction of proline was a 0.5 Å movement of Tyr540 to avoid a steric clash with the proline C5.
Preparation and functional analysis of PutA261. The gene encoding a truncated E. coli PutA protein containing the first 261 residues (PutA261) was engineered by positioning an EagI site immediately after codon 261 in the pUT669 construct (putA669 gene in a pET23b vector) using the QuikChange (Stratagene) sitedirected mutagenesis kit. The product of the QuikChange reaction was cut with EagI to remove codons 262-669 and then ligated to generate PutA261 in a pET23b vector carrying a C-terminal His 6 -tag (Novagen). The resulting construct, pUT261, was introduced into the E. coli expression strain BL21(DE3) pLysS. Nucleotide sequencing of pUT261 showed no mutations were introduced during the QuikChange protocol.
PutA261 with the C-terminal His 6 -tag was expressed in E. coli by induction with 0.5 mM IPTG at 0.8-1.0 OD 600 for 5 h at 28 °C. PutA261 was purified by Ni 2+ NTA affinity chromatography The binding of PutA261 to put control intergenic DNA was measured by nondenaturing gel mobility shift assays as described 15 . PutA261 (0-400 nM monomer) was incubated with put control intergenic DNA (20 nM) in a total volume of 25 µl in 70 mM Tris-HCl, pH 7.5, containing 10% (v/v) glycerol and 2 mM EDTA for 20 min before electrophoresis. Nonspecific ΦX174 ladder DNA was also added to PutA261 binding mixtures to demonstrate the change in migration of the put control DNA upon complex formation with PutA261 and the specificity of PutA261 DNA binding. For comparison, binding reactions were performed with PutA (500 nM monomer) and PutA669 (500 nM monomer) under identical conditions. PutA protein concentrations were determined spectrophotometrically at 451 nm by the bicinchoninic acid (BCA) method (Pierce) using bovine serum albumin as the standard.
Coordinates. Coordinates and structure factors have been deposited in the Protein Data Bank (accession code 1K87).
